Clean ClAImsFirst Pass

Aspirion

Complex claims and denials recovery for hospitals

Our take

Aspirion, based in Columbus, Georgia, recovers claims revenue that hospitals would otherwise lose. Its specialists, including in-house attorneys and clinicians, work denials, underpayments, and aged AR, along with complex claim types most provider billing offices struggle with: motor vehicle accident and third-party liability, workers' compensation, VA and TRICARE, and out-of-state Medicaid. The company layers AI and machine learning over this workforce to prioritize claims and generate appeals faster. Contracts are typically contingency-based, so hospitals pay from what is recovered.

Aspirion serves more than 140 clients across 45 states, including a large share of the biggest US health systems, and won Best in KLAS for denials management in both 2024 and 2025. Linden Capital Partners, a healthcare-focused private equity firm, acquired the company from Aquiline in 2022, and Aspirion has since expanded through acquisitions including Continuum Health Solutions, FIRM, and Boost Healthcare, the last adding zero-balance review, payment variance, and No Surprises Act work. Buyers should view it as a specialist recovery partner that complements, rather than replaces, core RCM operations.

What it does

  • Clinical and technical denials appeals with attorney support
  • Motor vehicle accident and workers' compensation claims
  • VA, TRICARE, and out-of-state Medicaid billing
  • Underpayment and zero-balance review
  • Aged AR resolution
  • AI-assisted appeal generation and claim prioritization

Where it's strong

  • Named 2025 Best in KLAS for denials management, its second consecutive year, which is rare third-party validation in this segment.
  • In-house attorneys and clinicians handle payer disputes most internal RCM teams cannot staff, and it serves over 140 clients including many of the largest US health systems.
  • Contingency-style pricing ties fees to actual recoveries, keeping downside risk low for the provider.

What buyers should weigh

  • It is a recovery service that works claims after the fact; it will not fix the upstream registration or coding problems causing the denials.
  • The company has absorbed several acquisitions (Boost Healthcare, FIRM, Continuum), so ask which team and toolset will actually work your inventory.
  • Contingency fees on high-dollar complex claims add up; model the effective rate against building internal capacity.

Latest

Aspirion was named 2025 Best in KLAS for denials management for the second straight year and closed its acquisition of Boost Healthcare, adding zero-balance and payment variance review.

Also in Denials & Appeals

Track this market

First Pass covers Denials & Appeals and the rest of the getting-paid stack every week.